Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial
Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page
- ChecktodayChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check7 days agoChange DetectedA site-wide banner announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe page continues to show a 403 Forbidden error, while the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the study record content. A Home link appears and the detailed study information is no longer accessible.SummaryDifference17%

- Check63 days agoChange DetectedThe page's Revision tag was updated from v3.6.5 to v3.6.6. This update represents an internal version change and does not alter the study details presented on the page.SummaryDifference0.1%

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.